Patents Assigned to Evaxion A/S
  • Vaccines targeting neoepitopes
    Patent number: 12622953
    Abstract: Methods of vaccination utilizing a cationic liposomal adjuvant admixed with at least one neoepitope and a solvent. Also provided are unit dosages and compositions for use in the methods.
    Type: Grant
    Filed: January 3, 2020
    Date of Patent: May 12, 2026
    Assignees: Evaxion A/S, Statens Serum Institut
    Inventors: Jens Kringelum, Anders Bundgård Sørensen, Birgitte Rønø, Nadia Viborg Petersen, Signe Tandrum Schmidt, Lars Vibe Andreasen, Dennis Christensen